Compare Inovio Pharmaceuticals Inc (INO) vs Levi Strauss & Co. (LEVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Levi Strauss & Co. — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Levi Strauss & Co. trades at $22.73 (market cap $8.75B). The key difference: Levi Strauss & Co. is far larger — about 111.4× Inovio Pharmaceuticals Inc's market cap, and Levi Strauss & Co. pays a 2.81% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | LEVI | |
|---|---|---|
Market Cap | $78.55M | $8.75B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $25.53 |
52-Week Low | $0.66 | $17.92 |
Enterprise Value | $49.56M | $10.07B |
Dividend Yield | — | 2.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Levi Strauss & Co.
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver
Read more on LEVI →
